Efficacy of Vonoprazan combined with high-dose Amoxicillin for eradication of <i>Helicobacter pylori</i>

Efficacy of Vonoprazan combined with high-dose Amoxicillin for eradication of <i>Helicobacter pylori</i>

Objective To evaluate clinical efficacy of the combination of Vonoprazan and high-dose Amoxicillin in the initial eradication treatment of <i>Helicobacter pylori</i> （Hp）. Methods Select 200 patients with Hp infection who have not undergone Hp eradication treatment in the past as the re...

Full description

Bibliographic Details
Main Author:	Liu Guohua, Zhou Xian, Ye Binming, Yang Tuying, Lin Hong
Format:	Article
Language:	zho
Published:	Editorial Office of Journal of New Medicine 2024-03-01
Series:	Xin yixue
Subjects:	<i>helicobacter pylori</i>\|vonoprazan\|dual therapy\|initial eradication
Online Access:	https://www.xinyixue.cn/fileup/0253-9802/PDF/1712537313853-988765878.pdf

Similar Items

Effect of Concomitant Use of Polaprezinc and Vonoprazan-Based Triple Therapy for <i>Helicobacter pylori</i> Eradication
by: Yuto Suzuki, et al.
Published: (2024-05-01)

Vonoprazan and high‐dose amoxicillin dual therapy for Helicobacter pylori first‐line eradication: A single‐arm, interventional study
by: Soichiro Sue, et al.
Published: (2023-01-01)

Efficacy and safety of bismuth quadruple regimens containing minocycline and vonoprazan for eradication of Helicobacter pylori: Real‐world evidence
by: Qiyunna He, et al.
Published: (2024-05-01)

Role of Vonoprazan in Helicobacter pylori Eradication Therapy in Japan
by: Mitsushige Sugimoto, et al.
Published: (2019-01-01)

The efficacy and mechanism of vonoprazan-containing triple therapy in the eradication of Helicobacter pylori
by: Zinan Zhang, et al.
Published: (2023-05-01)

The Efficacy and Safety of Vonoprazan and Amoxicillin Dual Therapy for <i>Helicobacter pylori</i> Infection: A Systematic Review and Network Meta-Analysis
by: Ligang Liu, et al.
Published: (2023-02-01)

Vonoprazan-amoxicillin combination therapy for Helicobacter pylori eradication: an umbrella review of meta-analyses
by: Saif Syed, et al.
Published: (2024-11-01)

Antibiotic Susceptibility-Guided Concomitant Therapy Regimen with Vonoprazan, High-Dose Amoxicillin, Clarithromycin, and Metronidazole for <i>Helicobacter pylori</i> Eradication as Fourth-Line Regimen: An Interventional Study
by: Soichiro Sue, et al.
Published: (2024-10-01)

The efficacy and safety of vonoprazan–amoxicillin dual therapy in eradicating Helicobacter pylori: a systematic review and meta-analysis
by: Jia-Hui Feng, et al.
Published: (2023-08-01)

Vonoprazan-amoxicillin dual therapy for Helicobacter pylori eradication: A systematic review and meta-analysis of randomized controlled trials
by: Ben-Gang Zhou, et al.
Published: (2023-01-01)

Effectiveness and safety of vonoprazan and amoxicillin dual regimen with Saccharomyces boulardii supplements on eradication of Helicobacter pylori
by: Jing Yu, et al.
Published: (2024-11-01)

Altered Gut Microbiota and Short-Chain Fatty Acids After Vonoprazan-Amoxicillin Dual Therapy for Helicobacter pylori Eradication
by: Yi Hu, et al.
Published: (2022-06-01)

Fourteen-day vonoprazan and low- or high-dose amoxicillin dual therapy for eradicating Helicobacter pylori infection: A prospective, open-labeled, randomized non-inferiority clinical study
by: Yi Hu, et al.
Published: (2023-01-01)

Vonoprazan versus Conventional Proton Pump Inhibitors Based Regimens in Helicobacter Pylori Eradication Therapy
by: Mohamed Ahmed, et al.
Published: (2023-10-01)

Alcohol increases treatment failure for Helicobacter pylori eradication in Asian populations
by: Jing Yu, et al.
Published: (2023-10-01)

Short-duration furazolidone therapy in combination with amoxicillin, bismuth subcitrate, and omeprazole for eradication of <i>Helicobacter pylori</i>
by: Hasan Salman, et al.
Published: (2010-01-01)

A Modified 14-Day Dual Therapy with Vonoprazan and Amoxicillin Amplified the Advantages Over Conventional Therapies for Eradication of Helicobacter pylori: A Non-Inferiority Clinical Trial
by: Li J, et al.
Published: (2023-08-01)

Efficacy of Vonoprazan-based triple therapy for cure of H. Pylori Infection among patients attending GIT outpatient clinic at Suez Canal University Hospital
by: Nageh Mahrous, et al.
Published: (2023-05-01)

Helicobacter pylori rescue treatment with vonoprazan, metronidazole, and sitafloxacin in the presence of penicillin allergy
by: Soichiro Sue, et al.
Published: (2021-02-01)

The impact of Helicobacter pylori eradication with vonoprazan-amoxicillin dual therapy combined with probiotics on oral microbiota: a randomized double-blind placebo-controlled trial
by: Ruolin Peng, et al.
Published: (2023-10-01)

Vonoprazan and Helicobacter pylori Treatment: A Lesson From Japan or a Limited Geographic Phenomenon?
by: Amin Talebi Bezmin Abadi, et al.
Published: (2019-04-01)

The Potential Benefits of Vonoprazan as <i>Helicobacter pylori</i> Infection Therapy
by: Muhammad Miftahussurur, et al.
Published: (2020-09-01)

Sex-specific Differences in Response to First-line Helicobacter pylori Eradication Therapy with vonoprazan, amoxicillin, and clarithromycin
by: Yusaku Kajihara
Published: (2020-07-01)

Best <i>Helicobacter pylori</i> Eradication Strategy in the Era of Antibiotic Resistance
by: Su Young Kim, et al.
Published: (2020-07-01)

Scope and Limitations of Current Antibiotic Therapies against <i>Helicobacter pylori</i>: Reviewing Amoxicillin Gastroretentive Formulations
by: Roberto Grosso, et al.
Published: (2022-06-01)

Comparison of vonoprazan dual therapy, quadruple therapy and standard quadruple therapy for Helicobacter pylori infection in Hainan: a single-center, open-label, non-inferiority, randomized controlled trial
by: Chen Chen, et al.
Published: (2024-04-01)

Treatment of <i>Helicobacter pylori</i> Infection in Patients with Penicillin Allergy
by: Ligang Liu, et al.
Published: (2023-04-01)

14-day pantoprazole- and amoxicillin-containing high-dose dual therapy for Helicobacter pylori eradication in elderly patients: A prospective, randomized controlled trial
by: Qinyu Yang, et al.
Published: (2023-02-01)

Effectiveness of vonoprazan-based regimens compared with proton pump inhibitor-based regimens as first-line Helicobacter pylori agents
by: Toshihiko Kakiuchi
Published: (2023-07-01)

Influence of patient characteristics on Helicobacter pylori eradication with Vonoprazan: A subgroup analysis of the pHalcon‐HP trial
by: William D Chey, et al.
Published: (2024-11-01)

Efficacy and safety of high-dose ilaprazole-amoxicillin dual therapy for Helicobacter pylori eradication: a prospective, single-center, randomized trial
by: Jianping Cheng, et al.
Published: (2023-11-01)

Effect of Antibiotic Susceptibility and <i>CYP3A4/5</i> and <i>CYP2C19</i> Genotype on the Outcome of Vonoprazan-Containing <i>Helicobacter pylori</i> Eradication Therapy
by: Mitsushige Sugimoto, et al.
Published: (2020-09-01)

Factors Influencing the Degree of Gastric Atrophy in <i>Helicobacter pylori</i> Eradication Patients with Drinking Habits
by: Kayoko Ozeki, et al.
Published: (2024-07-01)

Eradication of Helicobacter Pylori in Iran: A Review
by: Hafez Fakheri, et al.
Published: (2018-01-01)

Relationship of the Difficulty of <i>Helicobacter pylori</i> Eradication with Drinking Habits and Allergic Disease
by: Kayoko Ozeki, et al.
Published: (2022-05-01)

The Effectiveness of Different Eradication Schemes for Pediatric <i>Helicobacter pylori</i> Infection—A Single-Center Comparative Study from Romania
by: Oana-Maria Rosu, et al.
Published: (2022-09-01)

The results of the effectiveness of pharmaceutical treatment of chronic gastritis with erosions associated with <i>Helicobacter pylori</i>with azithromycin and amoxicillin in the elderly
by: T. E. Afanasenkova, et al.
Published: (2024-04-01)

Crises in Antimicrobial Stewardship: Misuse of Clarithromycin for <i>Helicobacter pylori</i> Therapy
by: David Y. Graham
Published: (2024-02-01)

Comparison of Amoxicillin Administered Twice versus Four Times a Day in First-Line <i>Helicobacter pylori</i> Eradication Using Tegoprazan, Clarithromycin, and Bismuth: A Propensity Score Matching Analysis
by: Jun-Hyung Cho, et al.
Published: (2024-09-01)

14-Day Vonoprazan-Based Bismuth Quadruple Therapy for Treatment-Naïve Patients with Helicobacter pylori Infection: A Retrospective Comparative Study
by: Lu F, et al.
Published: (2023-09-01)